A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Public ClinicalTrials.gov record NCT06610201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Velora Discover: A Prospective, Screening Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Study identification
- NCT ID
- NCT06610201
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Hemab ApS
- Industry
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Clinical outcomes of patients with VWD, Type 1 Other
- Clinical outcomes of patients with VWD, Type 2A, Type 2M, Type 2N, or Type 3 Other
Other
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2024
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Apr 20, 2026
2024 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 13
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | Recruiting |
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202-3591 | Recruiting |
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | Recruiting |
| University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | Recruiting |
| Emory Children's Center | Atlanta | Georgia | 30329 | Recruiting |
| Innovative Hematology, Inc./Indiana Hemophilia and Thrombosis Center | Indianapolis | Indiana | 46260 | Recruiting |
| Tulane University School of Medicine | New Orleans | Louisiana | 70112-2699 | Recruiting |
| University of Michigan Hospitals, Department of Hemophilia and Coagulation Disorders | Ann Arbor | Michigan | 48109 | Recruiting |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | Recruiting |
| Oregon Health & Science University | Portland | Oregon | 97239-3098 | Recruiting |
| Hemophilia Center of Western Pennsylvania | Pittsburgh | Pennsylvania | 15213 | Recruiting |
| The University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Recruiting |
| Washington Institute For Coagulation (WIC) | Seattle | Washington | 98101 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06610201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06610201 live on ClinicalTrials.gov.